HeartSciences Inc.
HSCS
$3.05
$0.0852.87%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.70K | 18.60K | 18.60K | 18.60K | 5.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.70K | 18.60K | 18.60K | 18.60K | 5.90K |
| Cost of Revenue | 4.60K | 6.10K | 6.10K | 6.10K | 2.30K |
| Gross Profit | 10.10K | 12.50K | 12.50K | 12.50K | 3.60K |
| SG&A Expenses | 3.50M | 3.53M | 3.44M | 3.67M | 3.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.48M | 7.07M | 6.32M | 6.04M | 5.81M |
| Operating Income | -7.47M | -7.05M | -6.31M | -6.02M | -5.81M |
| Income Before Tax | -7.62M | -7.29M | -6.61M | -6.39M | -6.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.62 | -7.29 | -6.61 | -6.39 | -6.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.62M | -7.29M | -6.61M | -6.39M | -6.09M |
| EBIT | -7.47M | -7.05M | -6.31M | -6.02M | -5.81M |
| EBITDA | -7.43M | -7.02M | -6.28M | -6.00M | -5.78M |
| EPS Basic | -10.79 | -24.43 | -35.03 | -49.05 | -62.28 |
| Normalized Basic EPS | -6.74 | -15.27 | -21.89 | -30.66 | -38.93 |
| EPS Diluted | -10.79 | -24.43 | -35.03 | -49.05 | -62.28 |
| Normalized Diluted EPS | -6.74 | -15.27 | -21.89 | -30.66 | -38.93 |
| Average Basic Shares Outstanding | 2.89M | 2.08M | 1.41M | 847.90K | 392.40K |
| Average Diluted Shares Outstanding | 2.89M | 2.08M | 1.41M | 847.90K | 392.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
